期刊
UROLOGIC CLINICS OF NORTH AMERICA
卷 34, 期 4, 页码 555-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ucl.2007.08.002
关键词
-
The long-standing concern that testosterone replacement therapy (TRT) may increase the risk of prostate cancer (PCa) has come under new scrutiny. Arguments used to support this concern lack a scientific basis. The original assertion by Huggins that administration of testosterone (T) caused enhanced growth of PCa was based on only a single patient. New evidence suggests that TRT has little, if any, negative impact on the prostate, even in men with a history of PCa. A saturation model is proposed that is consistent with regression of cancer when T is reduced to castrate levels and with lack of observed growth when serum T is increased.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据